Theranos Lab Threatened With CMS Ban, But The Firm Says Corrections Have Been Made
This article was originally published in The Gray Sheet
Deficiencies that have gone uncorrected by closely watched lab firm Theranos prompted a proposed sanctions letter from CMS last month that threatens barring one of the firm's two laboratories from operating. But Theranos has recently attested that it is cooperating with CMS and that it has since adopted significant quality upgrades in response to the agency's observations.
Register for our free email digests: